Loading: 100%
ALNYLAM PHARMACEUTICALS, INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 514 (as per Q2 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker ALNYno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1704080120160
datesClosing price (adj.)
13.10.2017123.00
11.10.2017124.86
04.10.2017120.16
27.09.2017113.46
20.09.2017113.78
13.09.201780.57
06.09.201786.02
30.08.201783.14
23.08.201784.81
16.08.201781.35
09.08.201780.53
02.08.201783.55
26.07.201781.57
19.07.201778.46
12.07.201778.90
05.07.201785.71
27.06.201779.83
20.06.201781.38
13.06.201774.31
06.06.201771.28
30.05.201764.09
23.05.201774.87
16.05.201772.01
09.05.201754.04
02.05.201753.07
25.04.201751.35
18.04.201749.73
11.04.201748.85
04.04.201750.16
28.03.201752.08
21.03.201754.21
14.03.201751.53
07.03.201749.94
28.02.201751.64
21.02.201746.86
14.02.201746.11
07.02.201740.46
31.01.201739.99
24.01.201737.62
17.01.201738.22
10.01.201744.71
03.01.201738.64
27.12.201641.04
19.12.201643.42
12.12.201642.61
05.12.201641.24
28.11.201645.31
21.11.201647.15
14.11.201650.04
07.11.201636.26
31.10.201635.60
24.10.201637.20
17.10.201636.58
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
123.00n/a
Market Capitalisation
in million USD
11,283n/a
Enterprise Value
in million USD
10,510n/a
Common Shares Outstanding
as per Jul 31, 2017
91,733,369n/a
Preferred Shares Outstanding
as per Jul 31, 2017
n/a
Average Basic Shares Outstanding
TTM
86,424,500n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 923n/a
Receivables 15n/a
Total Current Assets 961n/a
PP&E 148n/a
Total Assets 1,434n/a
Accounts Payable 23n/a
Current Debt 0n/a
Total Current Liabilities 109n/a
Long-Term Debt 150n/a
Total Liabilities 311n/a
Total Equity 1,123n/a
Cash Flow
Depreciation & Amortisation 13n/a
Change in Working Capital 14n/a
Operating Cash Flow -335n/a
Net Change in PP&E and Intangibles -98n/a
Investing Cash Flow 76n/a
Dividends Paid 0n/a
Financing Cash Flow 396n/a
Total Change in Cash 138n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 12.99n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 9.47n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.10n/a
Other Ratios
Current Ratio 883.6%n/a
Liabilities to Equity Ratio 27.7%n/a
Debt to Assets Ratio 10.5%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
96
101
100
83
67
47
51
41
47
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
96
101
100
83
67
47
51
41
47
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-124
-149
-144
-138
-131
-140
-235
-337
-472
Selling, General & Administrative
-27
-40
-38
-38
-45
-27
-45
-61
-89
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-97
-109
-106
-99
-87
-113
-190
-276
-382
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
-28
-48
-44
-55
-64
-93
-184
-296
-425
Non-Operating Income (Loss)
-12
-6
-4
-1
-1
-1
-4
-6
-14
Interest Expense, net
-14
-5
-2
-1
-1
-1
-3
-6
-8
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
2
-1
-2
1
0
0
-2
0
-6
Pretax Income (Loss), Adjusted
-39
-54
-48
-55
-66
-94
-189
-302
-439
Abnormal Gains (Losses)
9
5
3
4
-77
0
-221
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-30
-49
-45
-52
-142
-94
-409
-302
-439
Income Tax (Expense) Benefit, net
-1
-1
-1
0
11
3
40
0
0
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-31
-50
-46
-52
-132
-91
-369
-302
-439
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-31
-50
-46
-52
-132
-91
-369
-302
-439
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
-31
-50
-46
-52
-132
-91
-369
-302
-439
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-31
-50
-46
-52
-132
-91
-369
-302
-439
Remarks
restated on Feb 18, 2011 n/a
calculated values,
restated on Feb 13, 2012 n/a
calculated values,
restated on Feb 19, 2013 n/a
calculated values,
restated on Feb 20, 2014 n/a
calculated values,
restated on Feb 13, 2015 n/a
calculated values,
restated on Feb 12, 2016 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
281
233
146
162
291
697
1,081
627
Cash & Cash Equivalents
n/a
137
75
70
51
53
75
181
194
Short Term Investments
n/a
144
159
76
110
238
622
900
433
Accounts & Notes Receivable
n/a
6
3
1
0
4
40
8
23
Accounts Receivable, Net
n/a
6
3
1
0
4
40
8
23
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
6
18
4
3
4
10
17
22
Prepaid Expenses
n/a
4
7
4
3
4
10
17
22
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
2
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
11
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
Total Current Assets
n/a
294
254
152
164
299
746
1,105
672
Property, Plant & Equipment, Net
n/a
18
18
15
20
16
22
28
115
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
154
117
114
103
105
280
252
325
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
16
4
1
0
0
32
1
152
Intangible Assets
n/a
1
0
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
9
0
1
0
0
32
1
2
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
6
4
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
0
0
150
Total Noncurrent Assets
n/a
188
139
130
123
121
333
281
591
Total Assets
n/a
481
393
282
288
421
1,080
1,387
1,263
Liabilities and owners' equity
Payables & Accruals
n/a
28 27966000
20 20428000
18 18140000
16 15978000
20 20056000
39 38791000
46 45585000
97 96583000
Accounts Payable
n/a
12 12489000
9 9312000
6 5800000
4 4420000
6 5896000
15 15111000
17 16787000
54 54465000
Accrued Taxes
n/a
6 5516000
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
10 9961000
11 11116000
12 12340000
12 11558000
14 14160000
24 23680000
29 28798000
42 42118000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
83 82767000
82 81618000
63 62850000
32 32367000
34 33808000
57 56543000
17 16514000
35 35116000
Deferred Revenue
n/a
82 81929000
81 81134000
62 62366000
31 31417000
33 32696000
24 23871000
15 15352000
34 33540000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
32 31667000
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
1 838000
0 484000
0 484000
1 950000
1 1112000
1 1005000
1 1162000
2 1576000
Total Current Liabilities
n/a
111 110733000
102 102046000
81 80990000
48 48345000
54 53864000
95 95334000
62 62099000
132 131699000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
150 150000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
193 192687000
133 132986000
83 82930000
105 105122000
96 96319000
48 47994000
60 59697000
61 60890000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
190 189884000
130 129974000
78 78487000
101 100874000
93 93394000
43 42983000
53 52965000
49 49392000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
3 2803000
3 3012000
4 4443000
4 4248000
3 2925000
5 5011000
7 6732000
11 11498000
Total Noncurrent Liabilities
n/a
193 192687000
133 132986000
83 82930000
105 105122000
96 96319000
48 47994000
60 59697000
211 210890000
Total Liabilities
n/a
303 303420000
235 235032000
164 163920000
153 153467000
150 150183000
143 143328000
122 121796000
343 342589000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
477 477081000
501 500866000
519 519158000
625 625401000
847 846865000
1,844 1844134000
2,507 2507048000
2,610 2610473000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-300 -299832000
-343 -343347000
-401 -400996000
-507 -507010000
-596 -596235000
-957 -956630000
-1,247 -1246703000
-1,657 -1656811000
Other Equity
n/a
1 716000
1 714000
0 -165000
16 15662000
20 19717000
49 48763000
4 4369000
-33 -33441000
Equity Before Minority Interest
n/a
178 177965000
158 158233000
118 117997000
134 134053000
270 270347000
936 936267000
1,265 1264714000
920 920221000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
178 177965000
158 158233000
118 117997000
134 134053000
270 270347000
936 936267000
1,265 1264714000
920 920221000
Total Liabilities & Equity
n/a
481 481385000
393 393265000
282 281917000
288 287520000
421 420530000
1,080 1079595000
1,387 1386510000
1,263 1262810000
Remarks restated on n/a restated on Feb 18, 2011 n/a restated on Feb 13, 2012 n/a restated on Feb 19, 2013 n/a restated on Feb 20, 2014 n/a restated on Feb 13, 2015 n/a restated on Feb 12, 2016 n/a restated on Feb 15, 2017 n/a restated on Aug 9, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-26
-48
-44
-58
-106
-89
-360
-290
-410
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
6
6
5
5
9
10
12
19
15
Non-Cash Items
23
20
34
21
-8
19
214
47
72
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
63
-50
-80
-56
-11
-8
-31
35
15
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
65
-72
-84
-87
-116
-69
-166
-189
-308
Change in Fixed Assets & Intangibles
-11
-15
-5
-1
-8
-4
-34
-13
-65
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
29
23
23
83
12
-126
-515
-307
357
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
0
6
0
0
0
0
0
-1
-150
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
18
14
18
82
3
-131
-549
-321
143
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-7
0
0
0
0
0
723
89
164
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
10
4
4
1
94
202
29
528
14
Increase in Capital Stock
10
4
4
1
94
202
29
528
14
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
-1
-16
0
-1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
3
4
4
1
93
201
736
616
178
Net Cash Before Disc. Operations and FX
87
-54
-63
-4
-19
2
22
106
13
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
87
-54
-63
-4
-19
2
22
106
13
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
Net Changes in Cash
87
-54
-63
-4
-19
2
22
106
13
Remarks
restated on Feb 18, 2011 n/a
calculated values,
restated on Feb 13, 2012 n/a
calculated values,
restated on Feb 19, 2013 n/a
calculated values,
restated on Feb 20, 2014 n/a
calculated values,
restated on Feb 13, 2015 n/a
calculated values,
restated on Feb 12, 2016 n/a
calculated values,
restated on Feb 12, 2016 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo